SENSEX 76267.25 (-0.03)
Nifty 50 23074.9 (0.01)
Nifty Bank 49562.45 (0.32)
Nifty IT 41814.7 (-0.37)
Nifty Midcap 100 50877.9 (-0.02)
Nifty Next 50 60955.8 (0.21)
Nifty Pharma 21188.15 (-0.29)
Nifty Smallcap 100 16060.7 (-0.08)
NIKKEI 225 38963.7 (0.42)
HANG SENG 21811.77 (2.43)
S&P 6098.25 (-0.10)
BSE Code : 524816 | NSE Symbol : NATCOPHARM | ISIN : INE987B01026 | Industry : Pharmaceuticals |
Hot Pursuit 10-Feb-2025 (10:39) NATCO Pharma gets final approval for its ANDA for Bosentan tablets
Corporate News 10-Feb-2025 (09:16) Natco Pharma receives USFDA approval for Bosentan tablets for oral suspension, 32mg
Hot Pursuit 06-Feb-2025 (13:06) Natco Pharma Ltd soars 3.15%, up for third straight session
Corporate News 31-Jan-2025 (10:24) Natco Pharma to hold board meeting
Hot Pursuit 30-Jan-2025 (12:57) NATCO Pharma gets approval for its ANDA for Everolimus tablets
Natco Pharma 13-Nov-2024
Natco Pharma 13-Aug-2024
Natco Pharma 28-May-2024
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others